Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2005 1
2006 2
2007 4
2008 3
2009 1
2011 2
2012 3
2013 2
2014 1
2016 4
2017 1
2018 5
2019 6
2020 1
2021 2
2022 7
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
The gut virome: A new microbiome component in health and disease.
Cao Z, Sugimura N, Burgermeister E, Ebert MP, Zuo T, Lan P. Cao Z, et al. Among authors: burgermeister e. EBioMedicine. 2022 Jul;81:104113. doi: 10.1016/j.ebiom.2022.104113. Epub 2022 Jun 23. EBioMedicine. 2022. PMID: 35753153 Free PMC article. Review.
The drug-induced phenotypic landscape of colorectal cancer organoids.
Betge J, Rindtorff N, Sauer J, Rauscher B, Dingert C, Gaitantzi H, Herweck F, Srour-Mhanna K, Miersch T, Valentini E, Boonekamp KE, Hauber V, Gutting T, Frank L, Belle S, Gaiser T, Buchholz I, Jesenofsky R, Härtel N, Zhan T, Fischer B, Breitkopf-Heinlein K, Burgermeister E, Ebert MP, Boutros M. Betge J, et al. Among authors: burgermeister e. Nat Commun. 2022 Jun 6;13(1):3135. doi: 10.1038/s41467-022-30722-9. Nat Commun. 2022. PMID: 35668108 Free PMC article.
Checkpoints and beyond - Immunotherapy in colorectal cancer.
Gutting T, Burgermeister E, Härtel N, Ebert MP. Gutting T, et al. Among authors: burgermeister e. Semin Cancer Biol. 2019 Apr;55:78-89. doi: 10.1016/j.semcancer.2018.04.003. Epub 2018 Apr 30. Semin Cancer Biol. 2019. PMID: 29716829 Review.
Caveats of caveolin-1 in cancer progression.
Burgermeister E, Liscovitch M, Röcken C, Schmid RM, Ebert MP. Burgermeister E, et al. Cancer Lett. 2008 Sep 18;268(2):187-201. doi: 10.1016/j.canlet.2008.03.055. Epub 2008 May 14. Cancer Lett. 2008. PMID: 18482795 Review.
Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial.
Ebert MP, Meindl-Beinker NM, Gutting T, Maenz M, Betge J, Schulte N, Zhan T, Weidner P, Burgermeister E, Hofheinz R, Vogel A, Angermeier S, Bolling C, de Wit M, Jakobs R, Karthaus M, Stocker G, Thuss-Patience P, Leidig T, Gaiser T, Kather JN, Haertel N. Ebert MP, et al. Among authors: burgermeister e. Lancet Healthy Longev. 2022 Jun;3(6):e417-e427. doi: 10.1016/S2666-7568(22)00116-7. Epub 2022 Jun 9. Lancet Healthy Longev. 2022. PMID: 36098320 Free article. Clinical Trial.
Perspectives of clinical proteomics in gastrointestinal cancer.
Ebert M, Xing X, Burgermeister E, Schmid R, Röcken C. Ebert M, et al. Among authors: burgermeister e. Expert Rev Anticancer Ther. 2007 Apr;7(4):465-9. doi: 10.1586/14737140.7.4.465. Expert Rev Anticancer Ther. 2007. PMID: 17428167 Review.
49 results